CMPS Stock Summary and Trading Ideas (Compass Pathways PLC - American Depository Shares | NASDAQ:CMPS)

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Compass Pathways PLC - American Depository Shares trades on the NASDAQ stock market under the symbol CMPS.

As of April 8, 2026, CMPS stock price climbed to $5.76 with 437,183 million shares trading.

CMPS has a beta of 0.96, meaning it tends to be less sensitive to market movements. CMPS has a correlation of 0.03 to the broad based SPY ETF.

CMPS has a market cap of $742.60 million. This is considered a Small Cap stock.

In the last 3 years, CMPS traded as high as $12.75 and as low as $2.25.

The top ETF exchange traded funds that CMPS belongs to (by Net Assets): ARKG, IBB, PSIL, GWX, BBC.

CMPS has outperformed the market in the last year with a price return of +113.3% while the SPY ETF gained +35.2%. However, in the short term, CMPS had mixed performance relative to the market. It has underperformed in the last 3 months, returning -26.3% vs -1.9% return in SPY. But in the last 2 weeks, CMPS shares have fared better than the market returning +10.3% compared to SPY +3.3%.

CMPS support price is $5.29 and resistance is $5.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMPS shares will trade within this expected range on the day.